In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Blue cells containing small red and green dots on a black background
In the Lab
Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs

Multiple copies of a gene called <em>YES1</em> appear to be responsible for certain precision drugs losing their effectiveness.
Clonal Hematopoiesis Complicates Clinical Genomic Profiling of Solid Tumors

This study demonstrates how clonal hematopoiesis (CH)–derived mutations could lead to erroneous reporting and treatment recommendations when tumor-only sequencing is employed. If data about the blood are not part of test results, mutations present in the blood may be misread as mutations in the tumor, which can potentially affect the therapies patients receive. Data presented at the annual meeting of the American Society of Clinical Oncology by Ahmet Zehir, PhD, Director of Clinical Bioinformatics at Memorial Sloan Kettering Cancer Center (MSK) was simultaneously published in <i>JAMA Oncology</i> on June 5.
Bioinformatician Ahmet Zehir stands at a whiteboard
Finding
Gene Mutations in the Blood Can Complicate Findings from Tumor Sequencing

A blood condition related to aging can lead to misinterpreting tumor data.
Crowded hall with ASCO signage
Roundup
Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.
medical oncologist Larry Norton
Q&A
Some Women with Early Breast Cancer May Not Need Chemotherapy, Study Says

The findings will change how women with intermediate-risk breast cancer are treated.
Zsofia Stadler presents at the ASCO meeting
Finding
Genomic Marker Is Associated with Lynch Syndrome, a Hereditary Cancer Condition, Across Many Different Cancers

Tumors with a biomarker called high microsatellite instability have been linked to inherited cancer mutations.
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Finding
Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.
MSK commencement
Event
2018 MSK Convocation and Commencement Celebrates Distinguished Scientists and Scholars

Degrees were presented and awards were given at the 39th annual ceremony, held on May 30.
An illustration showing the process of CAR T cell therapy
In the Lab
Study Identifies New Way to Combat a Serious CAR T Cell Therapy Side Effect

By uncovering the root cause of cytokine release syndrome, MSK researchers have found a way to stop it.
Gabriella and Roseann Tucci pose on a Pediatrics floor
Q&A
Like Mother, Like Daughter: Meet MSK Pediatric Nurses Roseann and Gabriella Tucci

Meet Roseann Tucci and her daughter Gabriella, both nurses dedicated to caring for patients in the Department of Pediatrics at Memorial Sloan Kettering.